Philippe Saiag (P Saiag)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Pharmaceutics

Cancers

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of cancer

APHP

University of Versailles (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

APHP Jun 01 1993

France

Head of department :: General and Oncologic dermatology

Education History

University of Versailles Feb 01 2018

France

PHD :: General and Oncologic Dermatology

Publications

Robin Zagala, Stéphane Dalle, Marie Beylot-Barry, Nicolas Meyer, Philippe Saiag, Nora Kramkimel, Celeste Lebbè, Ouidad Zehou, Mona Amini-Adle, Jean-Jacques Grob, Jean-Philippe Arnault, Julia Sanchez, Florence Granel-Brocard, Bernard Cribier, Gaelle Quereux, Florence Brunet-Possenti, Sophie Dalac, Olivier Dereure, Elodie Drumez, Laurent Mortier, Maxime Battistella, Thomas Jouary
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Marie Bellouard, Jean Donadieu, Pauline Thiebot, Etienne Giroux-Leprieur, Philippe Saiag, Isabelle Etting, Pamela Dugues, Emuri Abe, Jean Claude Alvarez, Islam Amine Larabi
Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations. Pharmaceutics 16 (1) (2023)
Marie Bellouard, Jean Donadieu, Pauline Thiebot, Etienne Giroux-Leprieur, Philippe Saiag, Isabelle Etting, Pamela Dugues, Emuri Abe, Jean Claude Alvarez, Islam Amine Larabi
Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations. Pharmaceutics 16 (1) (2023)
Marie Bellouard, Jean Donadieu, Pauline Thiebot, Etienne Giroux-Leprieur, Philippe Saiag, Isabelle Etting, Pamela Dugues, Emuri Abe, Jean Claude Alvarez, Islam Amine Larabi
Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations. Pharmaceutics 16 (1) (2023)
Charlée Nardin, Aymeric Hennemann, Kadiatou Diallo, Elisa Funck-Brentano, Eve Puzenat, Valentine Heidelberger, Géraldine Jeudy, Mahtab Samimi, Candice Lesage, Lise Boussemart, Lucie Peuvrel, Jacques Rouanet, Florence Brunet-Possenti, Emilie Gerard, Alice Seris, Thomas Jouary, Mélanie Saint-Jean, Marc Puyraveau, Philippe Saiag, François Aubin
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC). Cancers 15 (14) (2023)
Philippe Saiag, Rafaele Molinier, Anissa Roger, Blandine Boru, Yves Otmezguine, Joelle Otz, Charles-Ambroise Valery, Astrid Blom, Christine Longvert, Alain Beauchet, Elisa Funck-Brentano
Efficacy of Large Use of Combined Hypofractionated Radiotherapy in a Cohort of Anti-PD-1 Monotherapy-Treated Melanoma Patients. Cancers 14 (17) (2022)
James S Wilmott, Hussein A Tawbi, Johnathan A Engh, Nduka M Amankulor, Brindha Shivalingam, Hiya Banerjee, Ismael A Vergara, Hansol Lee, Peter A Johansson, Peter M Ferguson, Philippe Saiag, Caroline Robert, Jean-Jacques Grob, Lisa H Butterfield, Richard A Scolyer, Joanne M Jeter, Georgina V Long, Michael A Davies
Clinical features associated with outcomes and biomarker analysis of dabrafenib plus trametinib treatment in patients with BRAF-mutant melanoma brain metastases. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Sandrine Monestier, Stéphane Dalle, Laurent Mortier, Caroline Dutriaux, Sophie Dalac-Rat, Nicolas Meyer, Marie Thérèse Leccia, Sandrine Mansard, Henri Montaudié, Philippe Saiag, Patrick Combemale, Bernard Guillot, François Skowron, Anne-Bénédicte Duval Modeste, Nathalie Bénéton, Ewa Hainaut, Caroline Robert, Jean Philippe Arnault, Yannick Le Corre, Thomas Jouary, Nabahet Ameur, Emilie Varey, Amir Khammari, Brigitte Dréno, null null
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study. International journal of cancer 148 (11) (2021)
R Molinier, Anissa Roger, B Genet, A Blom, C Longvert, L Chaplain, M Fort, Philippe Saiag, Elisa Funck-Brentano
Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
E Charvet, N Kramkimel, L Chaplain, A Gantzer, O Kassem, C Longvert, A Blom, Nicolas Dupin, S Aractingi, M Hamon, U Zimmermann, Jean François Emile, Pierre Sohier, T Sidibé, Philippe Saiag, Elisa Funck-Brentano
Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies. The British journal of dermatology 184 (4) (2020)
Elisa Funck-Brentano, Bouchra Baghad, Magali Fort, Iman Aouidad, Anissa Roger, Alain Beauchet, Yves Otmezguine, Astrid Blom, Christine Longvert, Blandine Boru, Philippe Saiag
Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti-PD-1 monotherapy. International journal of cancer 147 (6) (2020)

Philippe Saiag.css-eqlu8i{font-size:small;padding-left:4px;} (P Saiag)

Publication Activity (10 Years)

Top Topics

Top Venues

Philippe Saiag (P Saiag)